Introduction von
Recklinghausen's disease is a relatively commonautosomal disorder linked to chromosome 17. The pulmonary manifestations of neurofibromatosis consist of diffuse interstitial fibrosis and bullae, either alone or in combination (1). Respiratory symptoms are usually mild, but about 20% of affected patients develop disabling disease. Wetreated a patient with the characteristic feature of distal acinar emphysemaon chest computed tomography (CT) and histologically-proven interstitial pneumonia. To our knowledge, no patient with a complication of distal acinar emphysemain von Recklinghausen's disease has been reported. Therefore, we report this case together with the result of a 5-year observation.
For editorial comment, see p 381.
Case Report
In 1991 , a 48-year-old man was admitted to our hospital for resection of skin tumors with tenderness. A diagnosis of neurofibromatosis had made on the basis of multiple cafe-au-lait spots, multiple histologically-proven neurofibromas and a family history of neurofibromatosis. In the preoperative investigations, his chest roentgenogram revealed diffuse reticular shadow and bullae in the bilateral upper lobes, though he had no respiratory symptoms. A chest CTdemonstrated low-attenuation area with comb-like remnant interstitium in the peri-pleura with upper lobe-dominant distributions (Fig. 1 ) . These findings are characteristic of a diagnosis of distal acinar emphysema. Pulmonary function tests revealed slight airway obstruction on his flow-volume curve (V25/HT: 55%) and 150% increased residual volume, but otherwise repeatedly within normal limits includingDLco (%VC: 107%; FEV1%: 77.5%; %DLco: 126%).
He smoked 1 pack of cigarettes per day for 20 years. later, TCC ofBALF were reduced to 41.8% (92xlO4/ml) ( Fig.  3) . At the same time, the concentration ofalbumin in BALFand KL-6 in serum were both decreased from 194 |ig/ml to 67 \igl ml, and from 333 U/ml to 179 U/ml, respectively. Examinations revealed that these markers fluctuated to some extent, but did not return to the initial levels (52-76x104/ml for TCC, 59-82 Hg/ml for BALF albumin, and 1 80-260 U/ml for BALF KL-6). He remains symptomlesswith no remarkable changes in objective examinations at present, 5 years from the first evaluation.
Discussion
The present patient showed characteristic pulmonary manifestations of von Recklinghausen's disease; i.e., interstitial pneumonia and cystic lesions (1). In addition to the cystic lesions commonlyobserved in patients with centrilobular emphysema, his chest CTshowed a remarkable peri-pleural lowattenuation with upper lobe predominance, which suggested a diagnosis of distal acinar emphysema(2). These attenuation areas could not be due to fibrosis because the finding ofhoneycombing fibrosis, which is in direct contrast to the definition of emphysema(3), was not seen. In consideration of his smoking history, this patient has distal acinar emphysemaindependent of interstitial pneumonia.
The interstitial pneumonia complicated in patients with von Recklinghausen's disease is generally indistinguishable from that of known or unknownetiology (1, 4). Oneof the characteristic features of the present patient was a marked hypercellularity in BALF.In fact, the total cell count of this patient was the most numerous that we have seen in our experience. Since the increased numbers of intra-alveolar macrophages were observed in both BALFand TBLBspecimens, and this finding is not infrequently observed in patients with von Recklinghausen ' s disease (5), a diagnosis of desquamative interstitial pneumoni- In the present patient the number of macrophages in BALF was markedly reduced following quitting smoking. This fact indicated that smoking likely contributed to the extremely increased alveolar macrophages of this patient. Smoking is well-known to increase alveolar macrophages (6); they produce elastase which destroy lung elastin, and then contribute to the pathogenesis of emphysema(7). Therefore, this scheme could be applied to this patient. The fact that he was of a relatively younger age (<50 years old) and an unusual type of the disease would need the modification in this patient. Interstitial pneumonia, a well-known complication of von Recklinghausen's disease, may influence the development of emphysema in this patient. There is a possibility that von Recklinghausen ' s disease itself mayincrease the sensitivity to smoking, though it has not been proved. Furthermore, Motoyamaet al mentioned in their report (8) that nerve growth factor, whose serum levels were reported to be increased in patients with von Recklinghausen' s disease (9), has protease activity, and may contribute to the pathogenesis of emphysemain patients with von Recklinghausen's disease. In anyway, quitting smoking seemed beneficial in this patient. This notion is supported by both the reduced serum KL-6 level and the albumin concentration in BALF.The idea of the former has been studied by us and is knownto be useful for evaluating the disease activity of pneumonitis (10, 1 1). The latter is a sensitive marker for inflammatory damage to the air-blood barrier (12). Further careful observation of this patient will determine the prognosis of these particular lung complications.
